Modular Phase I/Ii Clinical Trial Evaluating The Selective Met-Kinase Inhibitor Omo-1 In Patients With Advanced Malignancies: Safety And Proof Of Mechanism.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 1|浏览93
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要